2026 NPPES data Pulmonary Disease Physician NPI 1922251792 MD
Verify on CMS →

ARTUR GRIGORIYAN, MD

Pulmonary Disease Physician in APPLE VALLEY, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
536
Medicare Part D claims · 106 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
32%
generic claims · 68% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$731.94
34 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ARTUR GRIGORIYAN, MD filed 536 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in APPLE VALLEY, California, prescribing 32% generic.

536
Part D claims, 2023
32%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ARTUR GRIGORIYAN, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

536 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

ARTUR GRIGORIYAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ARTUR GRIGORIYAN, MD?

Quality data not reported

NPI registry status

Active

Issued 10/24/2008

NPI 1922251792

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

536 63% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

Specialty distribution in California

How Pulmonary Disease Physician compares to other specialties among California providers

California providers

Pulmonary Disease Physician share within California

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pulmonary Disease Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pulmonary Disease Physician ABMS/AOA estimate

Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ARTUR GRIGORIYAN, MD appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding MD credentials at 18012 WIKA RD, APPLE VALLEY, CA, 92307, with a listed phone of (442) 292-2358. NPI 1922251792 was issued on 10/24/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GRIGORIYAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 536 prescription claims written by this provider, covering 106 Medicare beneficiaries and totaling roughly $472K in drug spend, split 68% brand-name and 32% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

18012 WIKA RD
APPLE VALLEY, CA 92307

Provider Details

NPI 1922251792
Specialty Pulmonary Disease Physician
Credentials MD
Gender Male
NPI Issued 10/24/2008

Hospital and facility affiliations

Facilities where ARTUR GRIGORIYAN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

HIGH DESERT PULMONARY ASSOCIATES INC
APPLE VALLEY, CA
RIDGECREST REGIONAL HOSPITAL
RIDGECREST, CA
Critical Access Hospitals
CMS CCN: 051333

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ARTUR GRIGORIYAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$732

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ARTUR GRIGORIYAN, MD. To verify ARTUR GRIGORIYAN, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

ARTUR GRIGORIYAN, MD — brand share 68.0%
Specialty average (est.)

68% brand-name claims vs 32% generic, on 536 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

536
Total Claims
$472K
Total Drug Cost
106
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
602
Total Day Supply
16,392
Brand vs Generic
68% brand / 32% generic
Brand Drug Cost
$390K
Antibiotic Claims
24

Patient Demographics

Average Patient Age
72.0 years
Avg HCC Risk Score
2.23
Gender Split
54% female / 46% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ARTUR GRIGORIYAN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
113
Spiriva Respimat
Tiotropium Bromide
55
Albuterol Sulfate Hfa
Albuterol Sulfate
46
Breo Ellipta
Fluticasone/Vilanterol
26
Ventolin Hfa
Albuterol Sulfate
25
Azithromycin
24
Stiolto Respimat
Tiotropium Br/Olodaterol Hcl
24
Breztri Aerosphere
Budesonide/Glycopyr/Formoterol
22
Fluticasone Propionate
21
Fluticasone-Salmeterol
Fluticasone Propion/Salmeterol
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How ARTUR GRIGORIYAN, MD fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

ARTUR GRIGORIYAN, MD's 536 claims are below the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as GRIGORIYAN.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ARTUR GRIGORIYAN, MD's specialty?
ARTUR GRIGORIYAN, MD specializes in Pulmonary Disease Physician and practices in APPLE VALLEY, California. Credentials: MD.
How much does ARTUR GRIGORIYAN, MD prescribe under Medicare Part D?
In 2023, ARTUR GRIGORIYAN, MD wrote 536 Medicare Part D claims totaling $472K in drug costs for 106 beneficiaries.
Where is ARTUR GRIGORIYAN, MD located?
ARTUR GRIGORIYAN, MD is located at 18012 WIKA RD, APPLE VALLEY, CA, 92307. Phone: (442) 292-2358.
What is ARTUR GRIGORIYAN, MD's NPI number?
ARTUR GRIGORIYAN, MD's National Provider Identifier (NPI) is 1922251792, issued on 10/24/2008.
Does ARTUR GRIGORIYAN, MD prescribe more brand-name or generic drugs?
ARTUR GRIGORIYAN, MD's prescribing is 68% brand-name and 32% generic drugs by claim count, with $390K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does ARTUR GRIGORIYAN, MD prescribe most often?
Based on 2023 Medicare Part D data, ARTUR GRIGORIYAN, MD's most frequently prescribed drugs include Trelegy Ellipta, Spiriva Respimat, Albuterol Sulfate Hfa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ARTUR GRIGORIYAN, MD accept Medicare?
ARTUR GRIGORIYAN, MD appears in CMS Medicare data with 536 Part D claims and 106 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ARTUR GRIGORIYAN, MD's credentials?
ARTUR GRIGORIYAN, MD's NPI is 1922251792 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology